secwatch.observer — SEC 8-K summary
======================================

Issuer:     Entera Bio Ltd. (ENTXW)
CIK:        0001638097
Form:       8-K
Filed at:   2022-09-02T23:59:59+00:00
Accession:  0001178913-22-003312
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Entera Bio enters into $5M ATM equity facility with SVB; terminates prior B. Riley ATM
--------------------------------------------------------------------------------

- Entered Sales Agreement with SVB Securities for at-the-market offering of up to 5,000,000 ordinary shares.
- Agent commission set at 3.0% of gross sales price per ordinary share sold.
- Prior B. Riley Securities ATM terminated effective Aug 30, 2022; no shares were sold under it.
- Net proceeds planned for general corporate purposes including R&D, clinical trials, and working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638097/000117891322003312/0001178913-22-003312-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638097/000117891322003312/zk2228415.htm
  HTML page:      https://secwatch.observer/filing/0001178913-22-003312

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer